K-numberK253132
Device nameSingle use stone retrieval balloons
ApplicantZhejiang Chuangxiang Medical Technology Co., Ltd.
Product codeFGE
Device classClass II
Decision dateMar 6, 2026
DecisionSubstantially Equivalent
Regulation876.5010
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Single use stone retrieval balloons is a single-use, sterile medical device comprised of a natural latex balloon mounted on a Pebax catheter with two or three internal lumens. It is indicated for endoscopic use to remove stones from the biliary system or to facilitate contrast medium injection while occluding the bile duct. The balloon inflates to diameters of 8.5 mm, 12 mm, 15 mm, or 18 mm and is designed for adult use only.

Technological characteristics

Key differences from the predicate include the use of tantalum instead of platinum-iridium alloy for radiopaque markers, a smaller minimum balloon size (8.5 mm vs. 9 mm), and the availability of two-lumen (non-injection) models in addition to three-lumen models. Both devices use natural latex balloons, Pebax catheters, EO sterilization, single-use packaging, 2-year shelf life, 200 cm working length, and are compatible with endoscopy channels ≥3.2 mm.

Test standards cited

ISO 13485 (Design controls, nonconforming product, corrective and preventative action), ISO 10993-1:2018 (Biocompatibility evaluation), ISO 11135 Second edition (EO sterilization requirements), ISO 10993-7 Second Edition (EO residual limits), ISO 11607-1 and ISO 11607-2 Second Edition (Sterile packaging). Bench testing included appearance, dimensions, flow rate, guidewire compatibility, endoscope compatibility, balloon strength, radio-detectability, and connection integrity.

Substantial equivalence argument

The proposed device is substantially equivalent to the predicate device because it is intended for the same clinical use (biliary stone removal and contrast injection), uses the same regulatory classification, materials, sterilization method, and packaging approach. Minor design differences (tantalum vs. platinum-iridium markers, slightly different balloon sizes, and optional two-lumen configuration) do not raise new safety or effectiveness concerns and are supported by biocompatibility and performance testing.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →